Inpharmatis office in KievFebruary 12, 2018
Ukrainian government simplifies registration of medicines from the U.S., EU and certain other developed countries
On June 16, 2016, the President of Ukraine signed the Amendments to the Medicines Act, which are intended to simplify the procedure of state registration of medicines coming from countries with strong established regulatory requirements, institutions, and procedures. The changes will become effective starting from their official publication day and responsible government agencies must still adjust certain bylaws to implement them.
Extended list of medicines subject to the simplified procedure
Now all medicines (drugs) registered by a competent authority of the USA (i.e., FDA), Switzerland, Canada, Australia, Japan, and the EU are now subject to the simplified registration procedure. Whereas the previous version of the Medicines Act allowed such simplified procedures only for medicines that treat tuberculosis, HIV/AIDS, viral hepatitis, oncological, and rare (orphan) illnesses.
Read Full article HERE.
Celebrating entrepreneurship at SLUSHDecember 05, 2017
Thanks to all participants of Strategy in Drug Regulatory Affairs CourseOctober 23, 2017
Join us at this years Regulatory Affairs Summit in Prague, 24-26 October, 2017October 06, 2017
Thanks to all who participated in ERA 2017 event in MallorcaJuly 27, 2017
Thanks to all who participated in Pharmacovigilance Strategy CourseMay 11, 2017
eCTD format only! From January 1, 2020May 02, 2017
eSubmissions Course, 6 - 7 April 2017, Riga, LatviaApril 10, 2017
Good Manufacturing Practice Course 2017 in Riga, LatviaMarch 21, 2017
European and US regulators agree on mutual recognition of inspections of medicines manufacturersMarch 06, 2017